BR0314088A - Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas - Google Patents
Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticasInfo
- Publication number
- BR0314088A BR0314088A BR0314088-1A BR0314088A BR0314088A BR 0314088 A BR0314088 A BR 0314088A BR 0314088 A BR0314088 A BR 0314088A BR 0314088 A BR0314088 A BR 0314088A
- Authority
- BR
- Brazil
- Prior art keywords
- birds
- adjuvant
- escherichia coli
- poultry
- coli toxin
- Prior art date
Links
- 241000588724 Escherichia coli Species 0.000 title abstract 3
- 239000002671 adjuvant Substances 0.000 title abstract 3
- 239000003053 toxin Substances 0.000 title abstract 3
- 231100000765 toxin Toxicity 0.000 title abstract 3
- 244000144977 poultry Species 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
"USO DE TOXINA DE ESCHERICHIA COLI LáBIL AO CALOR COMO UM ADJUVANTE EM PáSSAROS E AVES DOMéSTICAS". A presente invenção refere-se à composições e método de emprego da toxina de E. coli lábil ao aquecimento (LT) e análogos conhecidos como adjuvantes em pássaros. A invenção também fornece composições e métodos para empregar LT produzida de planta, seus análogos conhecidos, e imunógenos protetores como vacinas em pássaros.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40635902P | 2002-08-27 | 2002-08-27 | |
PCT/US2003/026721 WO2004020585A2 (en) | 2002-08-27 | 2003-08-27 | Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0314088A true BR0314088A (pt) | 2005-07-19 |
Family
ID=31978291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0314088-1A BR0314088A (pt) | 2002-08-27 | 2003-08-27 | Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040146533A1 (pt) |
EP (1) | EP1551451B1 (pt) |
JP (1) | JP2005539039A (pt) |
CN (1) | CN100435844C (pt) |
AR (1) | AR041090A1 (pt) |
AT (1) | ATE423569T1 (pt) |
AU (1) | AU2003274925A1 (pt) |
BR (1) | BR0314088A (pt) |
CA (1) | CA2491568A1 (pt) |
DE (1) | DE60326369D1 (pt) |
ES (1) | ES2320119T3 (pt) |
WO (1) | WO2004020585A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100387719C (zh) * | 2005-05-09 | 2008-05-14 | 中国农业科学院生物技术研究所 | 编码大肠杆菌热敏毒素基因及其表达载体和用途 |
ES2545265T3 (es) * | 2006-03-30 | 2015-09-09 | Zoetis Services Llc | Procedimientos y composiciones de vacunación de aves de corral |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
EP2329845A4 (en) * | 2008-08-18 | 2013-08-14 | Kitasato Daiichi Sankyo Vaccine Co Ltd | BIRD GRAPEVIRUS ANTIGEN AND BOOSTER IMMUNIZATION PROCEDURE FOR BIRD FLUID VACCINE IN COMBINATION WITH A MUCOSAL ADJUVAN WITH EFFICACY THROUGH ORAL ADMINISTRATION |
MX351643B (es) * | 2009-12-28 | 2017-10-23 | Merial Ltd | Antigeno ndv recombinante y usos del mismo. |
AR088028A1 (es) * | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002484A1 (en) * | 1988-09-06 | 1990-03-22 | Washington University | Oral immunization by transgenic plants |
IT1253009B (it) * | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
US6019982A (en) * | 1994-08-26 | 2000-02-01 | The Administrators Of The Tulane Educational Fund | Mutant enterotoxin effective as a non-toxic oral adjuvant |
JPH10507916A (ja) * | 1994-10-24 | 1998-08-04 | ザ テキサス エーアンドエム ユニバーシティ システム | トランスジェニック植物による経口免疫 |
US6395964B1 (en) * | 1995-10-24 | 2002-05-28 | The Texas A&M University System | Oral immunization with transgenic plants |
WO2000037609A2 (en) * | 1998-12-22 | 2000-06-29 | Boyce Thompson Institute For Plant Research At Cornell | Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
-
2003
- 2003-08-27 US US10/648,994 patent/US20040146533A1/en not_active Abandoned
- 2003-08-27 JP JP2004531491A patent/JP2005539039A/ja active Pending
- 2003-08-27 ES ES03759205T patent/ES2320119T3/es not_active Expired - Lifetime
- 2003-08-27 EP EP03759205A patent/EP1551451B1/en not_active Expired - Lifetime
- 2003-08-27 CN CNB038201798A patent/CN100435844C/zh not_active Expired - Fee Related
- 2003-08-27 CA CA002491568A patent/CA2491568A1/en not_active Abandoned
- 2003-08-27 BR BR0314088-1A patent/BR0314088A/pt not_active IP Right Cessation
- 2003-08-27 DE DE60326369T patent/DE60326369D1/de not_active Expired - Lifetime
- 2003-08-27 AT AT03759205T patent/ATE423569T1/de not_active IP Right Cessation
- 2003-08-27 AU AU2003274925A patent/AU2003274925A1/en not_active Abandoned
- 2003-08-27 WO PCT/US2003/026721 patent/WO2004020585A2/en active Application Filing
- 2003-08-28 AR ARP030103129A patent/AR041090A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1551451A2 (en) | 2005-07-13 |
US20040146533A1 (en) | 2004-07-29 |
EP1551451A4 (en) | 2005-11-16 |
ATE423569T1 (de) | 2009-03-15 |
WO2004020585B1 (en) | 2004-10-07 |
CA2491568A1 (en) | 2004-03-11 |
ES2320119T3 (es) | 2009-05-19 |
CN1678343A (zh) | 2005-10-05 |
EP1551451B1 (en) | 2009-02-25 |
DE60326369D1 (de) | 2009-04-09 |
WO2004020585A2 (en) | 2004-03-11 |
CN100435844C (zh) | 2008-11-26 |
AU2003274925A8 (en) | 2004-03-19 |
WO2004020585A3 (en) | 2004-08-12 |
AR041090A1 (es) | 2005-05-04 |
JP2005539039A (ja) | 2005-12-22 |
AU2003274925A1 (en) | 2004-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT777490E (pt) | Enterotoxina mutante eficaz como adjuvante oral nao toxico | |
BR9510263A (pt) | Novo derivado de ciclodextrina processo para sua preparação utilização dos mesmos composição terapêutica e adjuvante para vacinas | |
BR0007936A (pt) | Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno | |
DK1459766T3 (da) | Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner | |
NO20015073D0 (no) | Vaksiner | |
DE69939706D1 (de) | Verbesserte adjuvant zusammensetzungen auf basis von saponin und damit zusammenhängende methoden | |
SG170127A1 (en) | Vaccine compositions comprising a saponin adjuvant | |
CY1107188T1 (el) | Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης | |
TNSN07387A1 (en) | C.perfringens alpha toxoid vaccine | |
ES2152292T3 (es) | Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91. | |
BR0111834A (pt) | Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno | |
BR0314088A (pt) | Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas | |
CY1110327T1 (el) | DTPa ΕΜΒΟΛΙΑ ΒΛΕΝΝΟΓΟΝΟΥ | |
ATE392216T1 (de) | Mycobakterieller impfstoff | |
AU2001284354A1 (en) | Immunological adjuvant compounds, compositions, and methods of use thereof | |
AR009650A1 (es) | Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna. | |
TW200503755A (en) | Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella | |
ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
AR011592A1 (es) | Metodo de creacion, o mantenimiento o para inducir una inmuno respuesta protectora o adaptativa a un virus hiv en un huesped | |
BRPI0417880A (pt) | vacina de combinação para a proteção de aves domésticas contra ornithobacterium rhinotracheale, uso de uma cepa de ornithobacterium rhinotracheale superatenuada viva e um vìrus de aves domésticas atenuado, método para a preparação de uma vacina de combinação, e, kit de vacinação | |
Köhler | 359 pages, 14 figs. Manual des Vaccinations et d'Immunoprevention, Eyquem André, Joseph Alouf, Alain Chippaux, Piccin Nuova Libraria, Berlin-Heidelberg-New York-London-Paris-Tokyo-Hong Kong (1998), soft cover, fFr 180.- | |
ES2127702A1 (es) | Vacuna frente a vibriosis producida por vibrio vulnificus biotipo 2 en anguilas. | |
EP0178928A3 (en) | Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2164 DE 26/06/2012. |